Department Of Biochemistry

An imaging probe developed at Vanderbilt detects retinal inflammation early and may allow therapeutic intervention to prevent blindness. Read More

The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt. Read More

Melanie Ohi, who holds a primary appointment in the Department of Cell and Development Biology, presents the next "Frontiers in Biochemistry" seminar Oct. 21. Read More

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.” Read More

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers. Read More

Neil Osheroff, Ph.D., has been named director of the Academy for Excellence in Education. He succeeds Lillian Nanney, Ph.D., who served as director since the Academy’s inception in 2007. Read More

New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections. Read More

The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility. Read More

Lisa Poole, a graduate student in the lab of David Cortez, Ph.D., received the 2016 Leon W. Cunningham Award for Excellence in Biochemistry last week during the Biochemistry Department’s annual retreat at the Student Life Center. Read More

Ray Stevens, the Provost Professor of Chemistry and Molecular Biology at the University of Southern California, presents the inaugural Stanley Cohen Lecture Friday, March 4. Read More

Please join us as Dr. Benjamin F. Cravatt III of the Scripps Research Institute presents the inaugural Richard Armstrong Lecture Friday, Feb. 26, from noon to 1 p.m. in Light Hall, Room 214. Read More

One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered. Read More

An enzyme that builds DNA is able to insert the wrong building blocks, which could generate mutations. Read More

Peter Agre, M.D., a Nobel laureate who advocates the use of medical science to advance international diplomacy, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Jan. 21, in room 208 Light Hall. Read More

Telomeres – the caps on the end of chromosomes – are a source of stress for a particular protein involved in copying DNA, a new study reports. Read More

Brandon Toyama, research associate at the Salk Institute for Biological Studies, presents a biochemistry seminar Jan. 5. Read More

Vanderbilt investigators have generated a “parts list” for the molecular machinery that duplicates DNA each time a cell divides. The research has implications for cancer therapies that target components of this machinery. Read More

Walter Chazin, Ph.D., director of the Vanderbilt Center for Structural Biology, is a recipient of a 2016 Fellow of the Biophysical Society award. Read More

St. Jude Children's Research Hospital's Stacey Ogden presents a seminar Nov. 6. Read More

Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections. Read More